APA (7th ed.) Citation

Takakura, M., Nakamura, M., Kyo, S., Hashimoto, M., Mori, N., Ikoma, T., . . . Inoue, M. (2010). Intraperitoneal administration of telomerase-specific oncolytic adenovirus sensitizes ovarian cancer cells to cisplatin and affects survival in a xenograft model with peritoneal dissemination. Cancer Gene Therapy, 17(1), 11. https://doi.org/10.1038/cgt.2009.44

Chicago Style (17th ed.) Citation

Takakura, M., et al. "Intraperitoneal Administration of Telomerase-specific Oncolytic Adenovirus Sensitizes Ovarian Cancer Cells to Cisplatin and Affects Survival in a Xenograft Model with Peritoneal Dissemination." Cancer Gene Therapy 17, no. 1 (2010): 11. https://doi.org/10.1038/cgt.2009.44.

MLA (9th ed.) Citation

Takakura, M., et al. "Intraperitoneal Administration of Telomerase-specific Oncolytic Adenovirus Sensitizes Ovarian Cancer Cells to Cisplatin and Affects Survival in a Xenograft Model with Peritoneal Dissemination." Cancer Gene Therapy, vol. 17, no. 1, 2010, p. 11, https://doi.org/10.1038/cgt.2009.44.